Scientex Berhad

KLSE:SCIENTX Stock Report

Market Cap: RM 6.8b

Scientex Berhad Valuation

Is SCIENTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SCIENTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SCIENTX (MYR4.4) is trading below our estimate of fair value (MYR8.87)

Significantly Below Fair Value: SCIENTX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SCIENTX?

Other financial metrics that can be useful for relative valuation.

SCIENTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA9x
PEG Ratio1.5x

Price to Earnings Ratio vs Peers

How does SCIENTX's PE Ratio compare to its peers?

The above table shows the PE ratio for SCIENTX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.6x
BKAWAN Batu Kawan Berhad
20.3xn/aRM 7.7b
PCHEM PETRONAS Chemicals Group Berhad
22.7x17.0%RM 45.0b
SENFONG Seng Fong Holdings Berhad
13.6x12.4%RM 779.4m
SAB Southern Acids (M) Berhad
69.8xn/aRM 431.3m
SCIENTX Scientex Berhad
12.5x8.2%RM 6.8b

Price-To-Earnings vs Peers: SCIENTX is good value based on its Price-To-Earnings Ratio (12.5x) compared to the peer average (31.6x).

Price to Earnings Ratio vs Industry

How does SCIENTX's PE Ratio compare vs other companies in the Asian Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.5%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.5%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: SCIENTX is good value based on its Price-To-Earnings Ratio (12.5x) compared to the Asian Chemicals industry average (22.3x).

Price to Earnings Ratio vs Fair Ratio

What is SCIENTX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SCIENTX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.5x
Fair PE Ratio15.7x

Price-To-Earnings vs Fair Ratio: SCIENTX is good value based on its Price-To-Earnings Ratio (12.5x) compared to the estimated Fair Price-To-Earnings Ratio (15.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SCIENTX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 4.40
RM 4.69
+6.5%
9.9%RM 5.48RM 4.15n/a7
Oct ’25RM 4.40
RM 4.69
+6.5%
9.9%RM 5.48RM 4.15n/a7
Sep ’25RM 4.09
RM 4.59
+12.3%
10.4%RM 5.41RM 4.00n/a7
Aug ’25RM 4.29
RM 4.59
+7.1%
10.4%RM 5.41RM 4.00n/a7
Jul ’25RM 4.35
RM 4.51
+3.6%
9.9%RM 5.41RM 4.00n/a7
Jun ’25RM 4.38
RM 4.15
-5.3%
6.5%RM 4.58RM 3.85n/a7
May ’25RM 4.20
RM 4.12
-1.8%
7.3%RM 4.58RM 3.68n/a7
Apr ’25RM 4.14
RM 4.12
-0.4%
7.3%RM 4.58RM 3.68n/a7
Mar ’25RM 3.85
RM 4.04
+4.9%
6.7%RM 4.40RM 3.63n/a7
Feb ’25RM 4.00
RM 4.03
+0.7%
6.3%RM 4.40RM 3.75n/a7
Jan ’25RM 3.81
RM 4.03
+5.7%
6.3%RM 4.40RM 3.75n/a7
Dec ’24RM 3.60
RM 3.98
+10.7%
9.2%RM 4.40RM 3.23n/a7
Nov ’24RM 3.58
RM 3.98
+11.3%
9.2%RM 4.40RM 3.23n/a7
Oct ’24RM 3.71
RM 3.98
+7.4%
9.2%RM 4.40RM 3.23RM 4.407
Sep ’24RM 3.80
RM 3.90
+2.5%
11.2%RM 4.40RM 2.99RM 4.097
Aug ’24RM 3.59
RM 3.90
+8.5%
11.2%RM 4.40RM 2.99RM 4.297
Jul ’24RM 3.45
RM 3.82
+10.7%
11.1%RM 4.40RM 2.99RM 4.356
Jun ’24RM 3.31
RM 3.82
+15.5%
11.5%RM 4.40RM 2.99RM 4.386
May ’24RM 3.41
RM 3.85
+12.9%
10.7%RM 4.40RM 2.99RM 4.207
Apr ’24RM 3.45
RM 3.85
+11.6%
10.7%RM 4.40RM 2.99RM 4.147
Mar ’24RM 3.64
RM 3.90
+7.3%
12.9%RM 4.80RM 2.99RM 3.857
Feb ’24RM 3.53
RM 3.90
+10.6%
12.9%RM 4.80RM 2.99RM 4.007
Jan ’24RM 3.22
RM 3.97
+23.3%
13.9%RM 4.80RM 2.99RM 3.817
Dec ’23RM 3.38
RM 4.09
+21.0%
11.4%RM 4.80RM 3.33RM 3.607
Nov ’23RM 3.28
RM 4.13
+25.8%
12.0%RM 4.80RM 3.32RM 3.586
Oct ’23RM 3.47
RM 4.11
+18.4%
11.2%RM 4.80RM 3.32RM 3.717

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y